Traders work on the floor of the New York Stock Exchange April 20, 2015.Reuters/Brendan McDermid n”>(Reuters) – U.S. stocks were mixed on Tuesday, with the Dow industrials pulled down by a handful of uninspiring earnings reports, while the Nasdaq was pushed higher by a proposed biotech merger.Travelers, DuPont and IBM shares weighed on the Dow. DuPont reported lower sales in […]
Traders work on the floor of the New York Stock Exchange April 20, 2015.Reuters/Brendan McDermid n”>(Reuters) – U.S. stocks were mixed on Tuesday, with the Dow industrials pulled down by a handful of uninspiring earnings reports, while the Nasdaq was pushed higher by a proposed biotech merger.Travelers (TRV.N), DuPont (DD.N) and IBM (IBM.N) shares weighed most on the Dow. DuPont […]
Some investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.
Biotech stocks fell more than 3%, their biggest one-day drop this year.
But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains of 3% for […]
Biotech investors have been here before.
Stocks are lower on Wednesday and the high-flying biotech sector is leading the way down, with the iShares ETF that tracks the sector falling more than 3%.
And as the sector has weakened over the last several days, this sell off is starting to look at lot like the sell off we saw in the sector […]
Shares of Sagent Pharmaceuticals Inc (NASDAQ: SGNT) and Impax Laboratories Inc (NASDAQ: IPXL) were up on Wednesday, after analysts at Deutsche Bank initiated coverage on Tuesday.
Sagent Pharmaceuticals
The analysts initiated coverage of Sagent with a Buy rating and a $29 price target. They say they have always liked the biotech company’s “focus on the attractive generic injectables segment but now believe […]
See the original post –
Forget Biotech, Look at these Top-Ranked ETFs on Health Day – ETF News And Commentary
[…]
Visit link:
US STOCKS-Wall St up on deals, biotech boost
[…]
Visit link:
Mylan Launches First Generic Version of …
See which stocks are being affected by Social Media
[…]
Over the course of this long bull market, biotech stocks have been very, very good for their owners. Perhaps too good. Investors have shown such rabid enthusiasm for biotechs—especially small, unproven companies that have yet to bring a drug to market—that some observers are using another b word to describe the high-flying sector: bubble.See Also: 8 Stocks Under $10 Worth […]
Source: Amgen, Flickr.The biotech sector is something of a roulette wheel for investors. The chances of being right are typically against you, but if you can land a winner every now and then the rewards can multiply many times over your initial bet.A majority of the biotech sector is comprised of clinical-stage pipelines or developing product portfolios which are still […]
